Abstract: PD06-04
Sources of Funding: None

Introduction

Multiple treatment options exist for men with localized prostate cancer. Shared decision making (SDM), a process in which clinicians and patients collaborate to make decisions that are well informed and consistent with patients&[prime] preferences and values, helps guide patients through this decision making process and improves patient satisfaction. The objective of this study was to evaluate the feasibility and initial outcomes of measuring SDM among men with newly diagnosed localized prostate cancer, and to assess patients&[prime] perceptions of the value of existing decision support resources.

Methods

Over a one year period, all men with newly diagnosed localized prostate cancer were enrolled prospectively in this pilot study at an academic tertiary care center. All men were referred for nurse navigation, were offered referral to urology and radiation oncology, and were provided access to a prostate cancer educational website. At the time of informed consent for their chosen managment option (surveillance, surgery, radiation), men were invited to complete CollaboRATE, a validated 3-question survey measuring perceptions of SDM, along with measures assessing the perceived value of available decision support resources. Descriptive and correlational analyses were conducted to examine the prevalence of SDM and its associations with the perceived value of decision support resources.

Results

Annualized volume of prostate cancer diagnosis within our medical center was 249 per year, and 132 patients (53%) completed CollaboRATE. Descriptive frequencies of perceived value and CollaboRATE scores are reported in Table 1. Correlations between CollaboRATE and perceived value scores were non-significant.

Conclusions

Routine measurement of SDM and patient perceptions of the value of decision support resources is feasible but challenging, and though the prevalence of SDM was high it was not optimal. Physicians represent the most highly valued decision support resource. Measuring SDM and the value of decision support services from the patient perspective provides useful information to improve the quality of care for patients with newly diagnosed localized prostate cancer.

Funding

None